Aegerion To Pay $40M To End Host Of Juxtapid Claims

By Rachel Graf · September 22, 2017, 5:20 PM EDT

Massachusetts-based biopharmaceutical company Aegerion Pharmaceuticals Inc. agreed Friday to pay about $40 million to end criminal and civil allegations by the U.S. Department of Justice and fraud charges brought by the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America v. Bloss, et al

Case Number

1:17-cv-11818

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Date Filed

September 22, 2017